Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.2B | 12.3B | 11.9B | 12.2B |
| Cost of revenue | 3.0B | 4.8B | 3.0B | 3.3B |
| Gross profit | 8.2B | 7.5B | 8.9B | 8.9B |
| Operating expense | ||||
| Research & development | 2.3B | 3.2B | 2.4B | 2.9B |
| Selling general and admin | 1.6B | 2.1B | 2.0B | 1.9B |
| Other operating expenses | — | — | — | — |
| Operating income | 3.5B | 510M | 2.2B | 1.7B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 494M | 496M | 505M | 521M |
| Other income expense | -33M | 161M | 9M | 116M |
| Pretax income | 3.0B | 175M | 1.7B | 1.3B |
| Tax provision | 509M | 99M | 461M | -398M |
| Net income | 2.5B | 76M | 1.2B | 1.7B |
| Basic EPS | 1.2 | 0.0 | 0.6 | 0.8 |
| Diluted EPS | 1.2 | 0.0 | 0.6 | 0.8 |
| Basic average shares | 1.7M | 1.7M | 1.7M | 1.7M |
| Diluted average shares | 1.7M | 1.7M | 1.7M | 1.7M |
| EBITDA | 5.0B | 1.7B | 5.1B | 4.7B |
| Net income from continuing op. | 2.5B | 76M | 1.2B | 1.7B |
| Minority interests | -6M | -4M | -4M | -4M |
| Preferred stock dividends | — | — | — | — |